陈颖雯, 王伟腾, 李路安, 施清瀛, 骆洁仪, 梁馨苓. 急性肾损伤向慢性肾脏病转化的肾脏脂质代谢特征[J]. 临床肾脏病杂志, 2024, 24(6): 484-493. DOI: 10.3969/j.issn.1671-2390.2024.06.007
    引用本文: 陈颖雯, 王伟腾, 李路安, 施清瀛, 骆洁仪, 梁馨苓. 急性肾损伤向慢性肾脏病转化的肾脏脂质代谢特征[J]. 临床肾脏病杂志, 2024, 24(6): 484-493. DOI: 10.3969/j.issn.1671-2390.2024.06.007
    Chen Ying-wen, Wang Wei-teng, Li Lu-an, Shi Qing-ying, Luo Jie-yi, Liang Xin-ling. Lipid signatures of acute kidney injury to chronic kidney disease transition[J]. Journal of Clinical Nephrology, 2024, 24(6): 484-493. DOI: 10.3969/j.issn.1671-2390.2024.06.007
    Citation: Chen Ying-wen, Wang Wei-teng, Li Lu-an, Shi Qing-ying, Luo Jie-yi, Liang Xin-ling. Lipid signatures of acute kidney injury to chronic kidney disease transition[J]. Journal of Clinical Nephrology, 2024, 24(6): 484-493. DOI: 10.3969/j.issn.1671-2390.2024.06.007

    急性肾损伤向慢性肾脏病转化的肾脏脂质代谢特征

    Lipid signatures of acute kidney injury to chronic kidney disease transition

    • 摘要:
      目的  探讨急性肾损伤(acute kidney injury,AKI)向慢性肾脏病(chronic kidney disease,CKD)转化中肾组织脂质代谢特征。
      方法  通过肾脏缺血再灌注损伤(ischemia-reperfusion injury,IRI)(双侧肾动脉夹闭30 min)构建AKI向CKD转化的小鼠模型。取第2天、第14天及第28天小鼠肾脏组织,通过超高效液相色谱串联质谱检测不同时间点IRI小鼠与假手术组小鼠肾脏脂质代谢,分析各组间脂质代谢差异,通过京都基因和基因组百科全书富集化分析揭示AKI向CKD转化脂质代谢所参与的重要通路。
      结果  IRI小鼠第2天血肌酐较假手术组明显升高,并伴有肾小管明显急性损伤;在第14天和28天时,IRI小鼠肾脏纤维化程度明显加重。我们总共检测到1715种脂质代谢物。代谢物主要成分分析显示,不仅IRI小鼠在各个时间点均与假手术组显示出不同脂质代谢特征,而且IRI小鼠不同时间点间的脂质代谢也存在较大差异。在AKI阶段,肾脏脂质代谢特征以中性脂质蓄积最为明显,而在IRI后14 d和28 d时,改变最明显的脂质代谢物为甘油磷脂及鞘脂。在IRI 28 d时,下调甘油磷脂(186种)种类多于上调甘油磷脂(132种)。在上调甘油磷脂中,烯基(乙烯基)醚-磷脂酰乙醇胺最为明显,而在下调磷脂中,磷脂酰甘油最为明显。京都基因和基因组百科全书富集化分析显示,在此阶段甘油磷脂代谢通路下调最为显著。
      结论  我们的研究显示,AKI向CKD转化整个过程中,肾脏脂质代谢发生了显著变化,并且急性期与慢性期的脂质组学同样存在明显差异。甘油磷脂,尤其是烯基(乙烯基)醚-磷脂酰乙醇胺下调、磷脂酰甘油上调可能在AKI向CKD转化后期肾脏纤维化中发挥了重要作用。我们的研究为未来研究脂质代谢在AKI向CKD转化中的作用与机制提供了基础。

       

      Abstract:
      Objective  To explore lipid signatures of renal tissue in acute kidney injury (AKI) and AKI-to-CKD transition by untargeted lipidomics.
      Methods  Ischemia-reperfusion injury (IRI) mice were subjected to bilateral renal pedicle clamping for 30 min. A murine model was established for longitudinally examining CKD progression after AKI and analyzing renal lipid metabolites by ultra-high performance liquid chromatography-tandem mass spectrometry.
      Results  The levels of serum creatinine (Scr) and blood urea nitrogen (BUN) were significantly elevated after IRI and acute tubular injury score rose obviously at Day 2 post-IRI. The levels of Scr and BUN declined at Day 14/28 post-IRI and yet failed to completely return to baseline with severe renal interstitial fibrosis. A total of 1715 lipid metabolites were identified. Marked differences existed in renal lipid metabolic profiles between IRI and sham-operated mice at the corresponding timepoint. And there were also distinct lipids characteristic among IRI groups. In AKI stage, renal neutral lipid accumulation was most pronounced. In AKI-to-CKD transition stage, the most distinguished features of lipid profile were changes of glycerophospholipids and Sphingolipids. At Day 28 post-IRI, the number of decreased glycerophospholipid was more than increased glycerophospholipid. The most pronounced increase of alkenyl (vinyl) ether-phosphatidylethanolamine and the most pronounced decrease of phosphatidylglycerol occurred at Day 28 post-IRI. KEGG pathway enrichment also indicated glycerophospholipid metabolism was a predominant pathway during AKI-to-CKD transition.
      Conclusion  Our study has revealed renal lipid signatures in the whole process of AKI to CKD transition. Glycerophospholipid, especially alkenyl(vinyl) ether-phosphatidylethanolamine and phosphatidylglycerol, might be an important lipid involved in AKI to CKD transition. It may facilitate the future study of pathogenesis and mechanism involved in AKI-to-CKD transition.

       

    /

    返回文章
    返回